Literature DB >> 2411222

125I-glycoconjugate labels for identifying sites of protein catabolism in vivo: effect of structure and chemistry of coupling to protein on label entrapment in cells after protein degradation.

J L Strobel, J W Baynes, S R Thorpe.   

Abstract

Residualizing radioactive labels are designed to remain entrapped within cells following degradation of a carrier protein, and have been used for identification of the tissue and cellular sites of plasma protein catabolism. In this study we describe a convenient synthesis and purification of a series of 125I-labeled glycoconjugates, and an evaluation of their efficiency of retention in liver following degradation of a model carrier protein, asialofetuin. Glycoconjugates were prepared in 65-90% yield by reductive amination of reducing sugars with aromatic amines using NaBH3CN. The products were purified in a single ion-exchange chromatographic step, and then labeled with 125I. The derivatives prepared were mono-and disubstituted lactitol-,cellobiitol-and glucitol-[125I]tyramine and lactitol-[125I]tyrosine. 125I-Glycoconjugates were coupled to asialofetuin using either cyanuric chloride or, for lactose-containing labels, by treatment with galactose oxidase followed by reductive amination with NaBH3CN. Attachment of labels by either procedure did not affect the normal rapid clearance of asialofetuin from the rat circulation nor its uptake and degradation in liver lysosomes. Leakage of 125I-labeled degradation products from cells was measured by following the kinetics of loss of whole-body radioactivity. We observed that degradation products from larger, disubstituted glycoconjugates were retained more efficiently than those from smaller and monosubstituted derivatives, and that glycoconjugates coupled to protein via reductive amination were retained in the body more efficiently than those coupled by cyanuric chloride. Overall, dilactitol-[125I]tyramine coupled to protein by reductive amination was entrapped most efficiently in liver.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411222     DOI: 10.1016/0003-9861(85)90071-2

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Catabolism of hirudin and thrombin-hirudin complexes in the rat.

Authors:  J Bichler; J W Baynes; S R Thorpe
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

2.  The fate of antibodies and their radiolabels bound to tumor cells in vitro: the effect of cross-linking at the cell surface and of anti-idiotype antibodies.

Authors:  G L Ong; V Marria; M J Mattes
Journal:  Cancer Immunol Immunother       Date:  1994-11       Impact factor: 6.968

3.  Truncated apo B-70.5-containing lipoproteins bind to megalin but not the LDL receptor.

Authors:  Z Chen; J E Saffitz; M A Latour; G Schonfeld
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

4.  A fluorescent residualizing label for studies on protein uptake and catabolism in vivo and in vitro.

Authors:  J L Maxwell; L Terracio; T K Borg; J W Baynes; S R Thorpe
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

5.  Biodistributions of air-filled albumin microspheres in rats and pigs.

Authors:  P Walday; H Tolleshaug; T Gjøen; G M Kindberg; T Berg; T Skotland; E Holtz
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

6.  Endocytosis of hyaluronic acid by rat liver endothelial cells. Evidence for receptor recycling.

Authors:  C T McGary; R H Raja; P H Weigel
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

7.  Differences between the catabolism and tumour distribution of intact monoclonal antibody (791T/36) and its Fab/c fragment in mice with tumour xenografts revealed by the use of a residualizing radiolabel (dilactitol-125I-tyramine) and autoradiography.

Authors:  S Demignot; M V Pimm; S R Thorpe; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

8.  Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.

Authors:  S Y Choi; L G Fong; M J Kirven; A D Cooper
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

9.  Quantification of the accumulation and degradation of beta-very-low-density lipoproteins in vivo using a 19F-containing residualizing label and n.m.r. spectroscopy.

Authors:  L A Meeh; J J Ackerman; S R Thorpe; A Daugherty
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

10.  Non-invasive detection of protein metabolism in vivo by n.m.r. spectroscopy. Application of a novel 19F-containing residualizing label.

Authors:  A Daugherty; N N Becker; L A Scherrer; B E Sobel; J J Ackerman; J W Baynes; S R Thorpe
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.